Purpose: The purpose of this study was to determine the protective effect of α-lipoic acid against oxidative damage in rabbit conjunctiva and cornea exposed to ultraviolet radiation. Methods: 20 rabbits weighing 2,500– 3,000 g were used, and we divided them into 4 groups with 5 randomly selected rabbits. The rabbits were exposed to 2 J/cm2/h of ultraviolet A radiation (UVA) in the range of 320–405 nm for 12 h per day within 90 days. The control group did not undergo any procedure, the UVA group was only exposed to UVA radiation. The PUVA group was treated with 8-methoxypsoralen and UVA. The α-lipoic acid group was administered 8-methoxypsoralen + UVA + α-lipoic acid. At the end of 90 days, the rabbits were killed by decapitation, and the eyes were enucleated. Both eyes of each rabbit were used for biochemical evaluation. Conjunctival and corneal free malondialdehyde (MDA), glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD) levels were compared among the groups. Results: Conjunctival free MDA levels were lower in the α-lipoic acid group compared with the UVA and PUVA groups (p < 0.05, p < 0.001, respectively). Both conjunctival SOD levels (p < 0.05, p < 0.01, respectively) and conjunctival GSH-PX levels (p < 0.01, p < 0.001, respectively) were higher in the α-lipoic acid group compared with other groups. Corneal free MDA levels were lower in the α-lipoic acid group compared with the UVA and PUVA groups (p < 0.01, p < 0.001, respectively). Both corneal SOD levels (p < 0.01, p < 0.01, respectively) and corneal GSH-PX levels (p < 0.01, p < 0.01, respectively) were higher in the α-lipoic acid group compared with the other groups. Conclusion: α-Lipoic acid which is considered as potent antioxidant protects the eye from the damaging effect of ultraviolet exposure.

Keywords:
α-Lipoic acid, Psoralen-UVA therapy, Ultraviolet A radiation, Antioxidants
1.
See JA, Weller P: Ocular complications of PUVA therapy. Australas J Dermatol 1993;34:1–4.
2.
Fujihara T, Nagano T, Endo K, Nakamura M, Nakata K: Lactoferrin protects against UV-B irradiation-induced corneal epithelial damage in rats. Cornea 2000;19:207–211.
3.
Andley U: Photooxidative stress; in Albert DM, Jacobiec FA (eds): Principles and Practice of Ophthalmology. Philadelphia, Saunders Co, 1994, vol 1, pp 575–590.
4.
Wang ZY, Huang MT, Ferraro T, Wong CQ, Lou YR, Reuhl K, Iatropoulos M, Yang CS, Conney AH: Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res 1992;52:1162–1170.
5.
Maitra I, Serbinova E, Trischler H, Packer L: Alpha lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats. Free Radic Biol Med 1995;18:823–829.
6.
Alvarez S, Boveris A: Antioxidant adaptive response of human mononuclear cells to UV-B: Effect of lipoic acid. J Photochem Photobiol B 2000;55:113–119.
7.
Dunnick JK, Forbes PD, Eustis SL, Hardisty JF, Goodman DG: Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation. Fundam Appl Toxicol 1991;16:92–102.
8.
Barker FM, Dayhaw-Barker P, Forbes PD, Davies RE: Ocular effects of treatment with various psoralen derivatives and ultraviolet A (UVA) radiation in HRA/Skh hairless mice. Acta Ophthalmol 1986;64:471–478.
9.
Boutros G, Koch HR, Jansen R, Jacob TJ, Duncan G: Effect of 8-methoxypsoralen on rat lens cations, membrane potential and protein levels. Exp Eye Res 1984;38:509–513.
10.
Obrosova IG, Fathallah L, Greene DA: Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: Effect of DL-alpha-lipoic acid. Eur J Pharmacol 2000;398:139–146.
11.
Block F, Schwarz M: Effects of antioxidants on ischemic retinal dysfunction. Exp Eye Res 1997;64:559–564.
12.
Orhan H, Marol S, Hepşen IF, Şahin G: Effects of some probable antioxidants on selenite-induced cataract formation and oxidative stress-related parameters in rats. Toxicology 1999;139:219–232.
13.
Sun Y, Oberley LW, Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497–500.
14.
Karatas F, Karatepe M, Baysar A: Determination of free malondialdeyde in human serum by high-performance liquid chromatography. Anal Biochem 2002;311:76–79.
15.
Cordis GA, Bagchi D, Maulik N, Das DK: High-performance liquid chromatographic method for the simultaneous detection of malondialdehyde, acetaldehyde, formaldehyde, acetone and propionaldehyde to monitor the oxidative stress in heart. J Chromatogr A 1994;661:181–191.
16.
Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158–169.
17.
Linetsky M, Chemoganskiy VG, Hu F, Ortwerth BJ: Effect of UVA light on the activity of several aged human lens enzymes. Invest Ophthalmol Vis Sci 2003;44:264–274.
18.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
19.
Wittenberg S: Solar radiation and the eye: A review of knowledge relevant to eye care. Am J Optom Physiol Optics 1986;63:676–689.
20.
Hamlet S, Lavin MF: Bovine ocular squamous cell carcinoma: Superoxide dismutase and catalase levels. Res Vet Sci 1987;42:68–72.
21.
Gupta AK, Anderson TF, Arbor A: Psoralen photochemotherapy. J Am Acad Dermatol 1987;17:703–734.
22.
Lafond G, Roy PE, Grenier R: Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation. Can J Ophthalmol 1984;19:173–175.
23.
Bardak Y, Özertürk Y, Özgüner F, Durmuş M, Delibaş N: Effect of melatonin against oxidative stress in ultraviolet-B exposed rat lens. Curr Eye Res 2000;20:225–230.
24.
Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynoneal. Methods Enzymol 1990;186:407–421.
25.
Pitts DG: The ocular ultraviolet action spectrum and protection criteria. Health Phys 1973;25:559–566.
26.
Hill JC, Maske R: Pathogenesis of pterygium. Eye 1989;3:218–226.
27.
Goralska M, Dackor R, Holley B, McGahan MC: Alpha lipoic acid changes iron uptake and storage in lens epithelial cells. Exp Eye Res 2003;76:241–248.
28.
Fuchs J, Milbradt R: Antioxidant inhibition of skin inflammation induced by reactive oxidants: Evaluation of the redox couple dihydrolipoate/lipoate. Skin Pharmacol 1994;7:278–284.
29.
Burkart V, Koike T, Brenner HH, Imai Y, Kolb H: Dihydrolipoic acid protects pancreatic islet cells from inflammatory attack. Agents Actions 1993;38:60–65.
30.
Bäck O, Hollstrom E, Liden S, Thorburn W: Absence of cataract ten years after treatment with 8-methoxypsoralen. Acta Derm Venereol 1980;60:79–80.
31.
Stern RS, Parrish JA, Fitzpatrick TB: Ocular findings in patients treated with PUVA. J Invest Dermatol 1985;85:269–273.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.